entospletinib
Showing 1 - 9 of 9
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Entospletinib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Aschaffenburg, Germany
- +14 more
Dec 17, 2021
Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)
Completed
- Anemia
- +13 more
- Entospletinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 29, 2021
Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)
Recruiting
- Nucleophosmin 1-mutated Acute Myeloid Leukemia
- Entospletinib
- +3 more
-
Duarte, California
- +60 more
Jul 20, 2022
Hematologic Malignancy, Acute Myeloid Leukemia Trial in Japan (Entospletinib, Daunorubicin, Cytarabine)
Terminated
- Hematologic Malignancy
- Acute Myeloid Leukemia
- Entospletinib
- +2 more
-
Fukui, Japan
- +5 more
Feb 21, 2020
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- Entospletinib
- Idelalisib
-
La Jolla, California
- +12 more
May 18, 2020
Acute Lymphoblastic Leukemia Trial in Canada, Germany, United States (Entospletinib, Vincristine, Dexamethasone)
Terminated
- Acute Lymphoblastic Leukemia
- Entospletinib
- +3 more
-
Duarte, California
- +12 more
Dec 23, 2019
Acute Myeloid Leukemia Trial in Canada, Germany, United States (Entospletinib, Daunorubicin, Cytarabine)
Terminated
- Acute Myeloid Leukemia
- Entospletinib
- +4 more
-
Los Angeles, California
- +16 more
Nov 13, 2019
Non-Hodgkin Lymphoma Trial in France, United States (Entospletinib, Vincristine)
Terminated
- Non-Hodgkin Lymphoma
- Entospletinib
- Vincristine
-
Hattiesburg, Mississippi
- +6 more
Mar 26, 2019